Tech Company Financing Transactions
DeepUl Funding Round
On 10/20/2022, DeepUl raised $12.8 million in Series B funding from CDTI, Alta Life Sciences and AXIS Participaciones Empresariales.
Transaction Overview
Company Name
Announced On
10/20/2022
Transaction Type
Venture Equity
Amount
$12,780,000
Round
Series B
Investors
Proceeds Purpose
The funds will be used to progress the development of DeepUll's first-in-class sepsis recognition platform towards the market.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Baldiri Reixac, 4-8, Barcelona Science Park
Barcelona, 08028
SE
Barcelona, 08028
SE
Phone
Undisclosed
Website
Email Address
Overview
DeepUll is a medical diagnostics company developing culture-free diagnostic solutions for sepsis and acute infections. Founded in 2020 in Barcelona by the founders of STAT-Dx (sold to QIAGEN in 2018), DeepUll has assembled a team of world-class experts to create rapid, affordable and accessible diagnostic solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jordi Carrera
Browse more venture capital transactions:
Prev: 10/20/2022: Cofertility venture capital transaction
Next: 10/20/2022: SubjectWell venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs